Clinical Trial
doi: 10.1016/j.jaad.2005.06.053.
Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial
Affiliations
- PMID: 16243150
- DOI: 10.1016/j.jaad.2005.06.053
Item in Clipboard
Clinical Trial
Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial
J Am Acad Dermatol.
2005 Nov.
Abstract
In this randomized, double-blind, phase III trial, patients with psoriasis received etanercept for 24 weeks or placebo for 12 weeks followed by etanercept for 12 weeks. At week 12, improvement in Dermatology Life Quality Index was 47% to 61% with etanercept compared with 11% with placebo (P < .0001). Etanercept rapidly and substantially improved patients' health-related quality of life.
Similar articles
-
Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.Br J Dermatol. 2005 Dec;153(6):1192-9. doi: 10.1111/j.1365-2133.2005.06948.x. Br J Dermatol. 2005. PMID: 16307657 Clinical Trial.
-
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.Arch Dermatol. 2007 Jun;143(6):719-26. doi: 10.1001/archderm.143.6.719. Arch Dermatol. 2007. PMID: 17576937 Clinical Trial.
-
A randomized trial of etanercept as monotherapy for psoriasis.Arch Dermatol. 2003 Dec;139(12):1627-32; discussion 1632. doi: 10.1001/archderm.139.12.1627. Arch Dermatol. 2003. PMID: 14676082 Clinical Trial.
-
Etanercept for the treatment of psoriasis.Skin Therapy Lett. 2006 Feb;11(1):1-4. Skin Therapy Lett. 2006. PMID: 16485060 Review.
-
Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus.J Eur Acad Dermatol Venereol. 2006 Sep;20(8):988-98. doi: 10.1111/j.1468-3083.2006.01707.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16922950
Cited by
-
Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology.An Bras Dermatol. 2019 Apr;94(2 Suppl 1):76-107. doi: 10.1590/abd1806-4841.2019940211. Epub 2019 Jun 30. An Bras Dermatol. 2019. PMID: 31166402 Free PMC article.
-
Short term efficacy of biological treatment for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis.Arch Dermatol Res. 2024 Oct 18;316(10):699. doi: 10.1007/s00403-024-03398-y. Arch Dermatol Res. 2024. PMID: 39424649
-
Psoriasis (chronic plaque).BMJ Clin Evid. 2009 Jan 9;2009:1706. BMJ Clin Evid. 2009. PMID: 19445765 Free PMC article.
-
A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis.Br J Dermatol. 2012 Sep;167(3):649-57. doi: 10.1111/j.1365-2133.2012.11015.x. Br J Dermatol. 2012. PMID: 22533447 Free PMC article. Clinical Trial.
-
Ustekinumab: a new option in psoriasis therapy.Drugs. 2009 Jun 18;69(9):1141-52. doi: 10.2165/00003495-200969090-00001. Drugs. 2009. PMID: 19537833 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
